Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH
Biomedicines（2021）
Key words
liver disease,non-alcoholic steatohepatitis,GLP-1 agonist,SGLT-2 inhibitor,type 2 diabetes,innate immune system,adaptive immune system,metabolic syndrome
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined